Literature DB >> 21917122

What is the frequency of carbohydrate metabolism disorder in CKD?

Taner Basturk1, Abdulkadir Unsal.   

Abstract

OBJECTIVE: The objective of this paper is to detect the incidence of insulin resistance (IR) in Chronic Kidney disease (CKD) patients and the presence of impaired fasting glucose (IFG), impaired glucose tolerance (IGT) and diabetes mellitus (DM) in patients with/without IR.
METHODS: We enrolled 113 patients with CKD. Biochemical parameters were investigated.
RESULTS: IFG was found 59.3% of patients with CKD. Age (p = 0.012), BMI (p = 0.036), TG (p = 0.008), HbA1c(p = 0.002), hs-CRP (p = 0.015) levels were higher in patients with IFG. According to the results of Oral glucose tolerance test (OGTT), 69% of patients with CKD had a detected carbohydrate metabolism disorder, 9.7% had DM, 59.3% had IGT. In patients with IFG 13.6% had DM, 31.8% IGT, in patients without IFG 4.2% had DM and 29.8% IGT. The mean HOMA-IR and insulin levels were 3.03 ± 1, 97/11.9 ± 7.13. IR was detected 23% of patients with CKD. In patients with IR; FBG (p = 0.003), serum insulin (p = 0.001), TG (p = 0.05) and HbA1c (p = 0.004) levels were elevated. 31.3% of patients with IFG were found to be IR.
CONCLUSION: Carbohydrate metabolism disorder and insulin resistance are found in patients with CKD. Most patients with CKD who are elderly, obesity or overweight offer targets for additional risk factors. For these reasons, screening for DM may be recommended.
© 2011 European Dialysis and Transplant Nurses Association/European Renal Care Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21917122     DOI: 10.1111/j.1755-6686.2011.00246.x

Source DB:  PubMed          Journal:  J Ren Care        ISSN: 1755-6678


  2 in total

1.  The association between insulin resistance and atrial fibrillation: A cross-sectional analysis from SPRINT (Systolic Blood Pressure Intervention Trial).

Authors:  Monique E Cho; Timothy E Craven; Alfred K Cheung; Stephen P Glasser; Mahboob Rahman; Elsayed Z Soliman; Randall S Stafford; Karen C Johnson; Jeffrey T Bates; Anna Burgner; Addison A Taylor; Leonardo Tamariz; Rocky Tang; Srinivasan Beddhu
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-09-03       Impact factor: 3.738

2.  Zuo Gui Wan Alters Expression of Energy Metabolism Genes and Prevents Cell Death in High-Glucose Loaded Mouse Embryos.

Authors:  Qi Liang; Zhipeng Qu; Yu Liang; QianJin Feng; Xin Niu; Temaka Bai; Yingli Wang; Qiang Song; David L Adelson
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-25       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.